
MGTX
NGSMeiraGTx Holdings plc
Healthcare•Biotechnology
Watchlists:
Last updated: Sunday 20th July 2025
8.62
No Change
Prev Close:8.62
Open:8.75
Bid:8.62
Ask:8.98
52 Week Range
3.858.98
Volume:534,869
Mkt Cap:689 M
57
MarketXLS Rank ®
Hold
Price Target
$9.91
+15.0%
Financial Statements
MGTX - Income Statement (Annual)
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Invalid date | |
---|---|---|---|---|---|---|---|---|
Accretion On Preferred Stock | 2 M | |||||||
Acquired In Process Rn D Income | 499000.0 | -434000.0 | ||||||
Depreciation And Amortization | 13 M | 14 M | 7 M | 6 M | 4 M | -2 M | -2 M | |
Earnings From Equity Interest | 499000.0 | |||||||
Earnings From Equity Interest Net Of Tax | 499000.0 | |||||||
Gain On Sale Of Business | 361000.0 | |||||||
General And Administrative Expense | 54 M | 47 M | 47 M | 44 M | 44 M | 47 M | 44 M | |
Gross Profit Margin (profit Margin After CGS) | 9 M | 14 M | 16 M | 38 M | 16 M | 13 M | ||
Interest Expense Non Operating | 13 M | 13 M | 5 M | 288000.0 | 139000.0 | 48612.0 | 33429.0 | |
Interest Income Operating | 361000.0 | |||||||
Misc Other Special Charges | 27 M | -1 M | ||||||
Net Income (loss) | -148 M | -84 M | -130 M | -80 M | -58 M | -55 M | -83 M | |
Net Income Common Stockholders | -148 M | -84 M | -130 M | -80 M | -58 M | -55 M | -85 M | |
Net Income Continuous Operations | -148 M | -84 M | -130 M | -80 M | -58 M | -55 M | -83 M | |
Net Non Operating Interest Income Expense | -9 M | -11 M | -4 M | -76000.0 | 1 M | 321991.0 | 19979.0 | |
Normalized Income | -116 M | |||||||
Operating Income | -164 M | -137 M | -116 M | -73 M | -63 M | -58 M | -78 M | |
Operating Income Before Depreciation (EBITDA) | -145 M | -66 M | -116 M | -71 M | -54 M | -52 M | -81 M | |
Operating Expense | 197 M | 151 M | 132 M | 110 M | 78 M | 72 M | -78 M | |
Other Gand A | 54 M | 47 M | 47 M | 44 M | 44 M | 47 M | 44 M | |
Other Operating Expenses | -756000.0 | -279000.0 | -165000.0 | -138000.0 | -2 M | -570525.0 | ||
Otherunder Preferred Stock Dividend | 2 M | |||||||
Preferred Stock Dividends | 2 M | |||||||
Rent And Landing Fees | -487555.0 | 44 M | ||||||
Research Expense | 119 M | 104 M | 86 M | 67 M | 34 M | 25 M | 34 M | |
Salaries And Wages | 28 M | -16 M | 21 M | 18 M | -16 M | -18 M | ||
Selling And Marketing Expense | 24 M | |||||||
Total Income Available For Interest Expense (EBIT) | -159 M | -80 M | -125 M | -79 M | -58 M | -55 M | -83 M | |
Total Revenues | 33 M | 14 M | 16 M | 38 M | 16 M | 13 M | ||
Total Expenses | 221 M | 151 M | 132 M | 110 M | 78 M | 72 M | -78 M | |
Total Revenue | 33 M | 14 M | 16 M | 38 M | 16 M | 13 M | ||
Amord | 1 M | 1 M | 1 M | 2 M | 539000.0 | -300229.0 | ||
Avgshs | 70 M | 56 M | 45 M | 44 M | 38 M | 33 M | 19 M | |
Avgshsdt | 70 M | 56 M | 45 M | 44 M | 38 M | 33 M | 19 M | |
Basiceps | -2.12 | -1.49 | -2.87 | -1.8 | -1.54 | |||
Basicepscont | -2.12 | -1.49 | -2.87 | -1.8 | -1.54 | |||
Cor | 24 M | |||||||
Depamor | 14 M | 7 M | 6 M | 4 M | -2 M | -2 M | ||
Dileps | -2.12 | -1.49 | -2.87 | -1.8 | -1.54 | -1.65 | -4.47 | |
Dilepscont | -2.12 | -1.49 | -2.87 | -1.8 | -1.65 | |||
Intinc | 4 M | 2 M | 777000.0 | 212000.0 | 1 M | 370603.0 | 53408.0 | |
Netincdisc | -148 M | -84 M | -130 M | -80 M | -58 M | -55 M | -83 M | |
Othincexp | -499000.0 | -9 M | 434000.0 | -27 M | 1 M | |||
Pretaxinc | -148 M | -152 M | -130 M | -80 M | -58 M | -55 M | -83 M | |
Resdev | 119 M | 104 M | 86 M | 67 M | 34 M | 25 M | 34 M | |
Sga | 78 M | 47 M | 47 M | 44 M | 44 M | 47 M | 44 M | |
Shsout | 79 M | 64 M | 49 M | 45 M | 44 M | 37 M | 33 M | |
Taxprov | -24 M | -10 M | -26 M | -37 M | -16 M | -474391.0 |